ADMA Biologics Inc. (ADMA)
NASDAQ: ADMA
· Real-Time Price · USD
17.63
0.64 (3.77%)
At close: Aug 18, 2025, 3:59 PM
17.63
0.03%
Pre-market: Aug 19, 2025, 05:00 AM EDT
ADMA Biologics Revenue
ADMA Biologics reported an annual revenue of $426.45M, reflecting a 65.15% growth. For the quarter ending June 30, 2025, ADMA Biologics generated $121.98M in revenue.
Revenue (ttm)
426.45M
Revenue Growth
65.15%
Price / Sales Ratio
9.37
Revenue / Employee
622.56K
Employees
685
Market Cap
4.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 426.45M | +65.15% |
| Dec 31, 2023 | 258.21M | +67.59% |
| Dec 31, 2022 | 154.08M | +90.36% |
| Dec 31, 2021 | 80.94M | +91.72% |
| Dec 31, 2020 | 42.22M | +43.85% |
| Dec 31, 2019 | 29.35M | +72.79% |
| Dec 31, 2018 | 16.99M | -25.37% |
| Dec 31, 2017 | 22.76M | +113.49% |
| Dec 31, 2016 | 10.66M | +48.53% |
| Dec 31, 2015 | 7.18M | +21.34% |
| Dec 31, 2014 | 5.92M | +92.84% |
| Dec 31, 2013 | 3.07M | +174.35% |
| Dec 31, 2012 | 1.12M | +Infinity% |
| Jun 30, 2011 | 0 | n/a |
| Jun 30, 2010 | 0 | n/a |
| Jun 30, 2009 | 0 | n/a |
| Jun 30, 2008 | 0 | n/a |
| Jun 30, 2007 | 0 | n/a |